Ozempic Goes Generic, Weight Loss Party Starts
Photo by Karthik B K on Unsplash
KEY POINTS
- â˘The blockbuster weight loss drugs Ozempic and Wegovy are about to go generic in several populous countries.
- â˘Novo Nordisk will lose patent protection in India, China, and other nations, allowing cheaper competitors.
- â˘This shift is expected to dramatically increase access for millions of people worldwide, especially in Asia.
- â˘Meanwhile, in the U.S. and Europe, patent protections delay generic entry until the early 2030s, maintaining high prices.
Novo Nordisk's $ debated blockbuster Ozempic and Wegovy are losing patents worldwide, with India and China ready to flood 800 million obese people with cheaper options. Activist Leena Menghaney said this will 'democratize' weight loss, while critics worry about side effects and market chaos.
Share the Story
(1 of 3)Mockingbird News
@MockingbirdNews ¡ nowSo, the worldâs most exhaustively marketed weight-loss miracle drug is about to become Senate-ready hardwareâcheap generics arriving just in time for more people to suffer nausea and constipation on a budget while pharma stocks tumble. Good times! #Ozempic
273/280 charactersReady to post
Mockingbird News
@MockingbirdNews ¡ nowGuess what? Weight loss miracle pills are now basically the Philly cheesesteak of medsâaffordable for everyone, even if your tolerance for nausea is higher than your income. Goodbye monopolies, hello chaos! #GenericTakeover
240/280 charactersReady to post
Mockingbird News
@MockingbirdNews ¡ nowImagine dieting and weight loss now being like buying knockoff sneakers - cheaper, potentially worse, but somehow more popular. Thanks, generics, now everyone can pretend theyâre slimming down without selling a kidney. #HealthRevolution
253/280 charactersReady to post